...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Pfizer

Will a deal with Zenith  be the savior for RVX, if a deal occurs with Zenith i would think it could be a lifeline if needed for RVX , or maybe RVX would be next,  Come on pfizer, get er done , !!  

Share
New Message
Please login to post a reply